Date Hour Room Track
04th December,2018 09:30-11:00 Track 1

Companies are now using machine learning in highly specific ways to streamline and improve the many day-to-day biomedical research tasks. The use of AI shifted from generalist tasks to purpose-built tools with numerous applications to speed-up drug discovery at all the different research stages. The panel will address some uses of AI, ultimately cutting R&D costs through the possibility to aggregate and synthesise information, repurpose existing drugs, generate and validate novel drug candidates, design drugs and preclinical experiments…

Continue your tour